Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait
Sickle cell trait affects approximately 8% of Black individuals in the United States, along with many other individuals with ancestry from malaria-endemic regions worldwide. While traditionally considered a benign condition, recent evidence suggests that sickle cell trait is associated with lower eG...
Gespeichert in:
Veröffentlicht in: | Clinical journal of the American Society of Nephrology 2023-11, Vol.18 (11), p.1416-1425 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1425 |
---|---|
container_issue | 11 |
container_start_page | 1416 |
container_title | Clinical journal of the American Society of Nephrology |
container_volume | 18 |
creator | Cai, Yanwei Franceschini, Nora Surapaneni, Aditya Garrett, Melanie E Tahir, Usman A Hsu, Li Telen, Marilyn J Yu, Bing Tang, Hua Li, Yun Liu, Simin Gerszten, Robert E Coresh, Josef Manson, JoAnn E Wojcik, Genevieve L Kooperberg, Charles Auer, Paul L Foster, Matthew W Grams, Morgan E Ashley-Koch, Allison E Raffield, Laura M Reiner, Alex P |
description | Sickle cell trait affects approximately 8% of Black individuals in the United States, along with many other individuals with ancestry from malaria-endemic regions worldwide. While traditionally considered a benign condition, recent evidence suggests that sickle cell trait is associated with lower eGFR and higher risk of kidney diseases, including kidney failure. The mechanisms underlying these associations remain poorly understood. We used proteomic profiling to gain insight into the pathobiology of sickle cell trait.
We measured proteomics ( N =1285 proteins assayed by Olink Explore) using baseline plasma samples from 592 Black participants with sickle cell trait and 1:1 age-matched Black participants without sickle cell trait from the prospective Women's Health Initiative cohort. Age-adjusted linear regression was used to assess the association between protein levels and sickle cell trait.
In age-adjusted models, 35 proteins were significantly associated with sickle cell trait after correction for multiple testing. Several of the sickle cell trait-protein associations were replicated in Black participants from two independent cohorts (Atherosclerosis Risk in Communities study and Jackson Heart Study) assayed using an orthogonal aptamer-based proteomic platform (SomaScan). Many of the validated sickle cell trait-associated proteins are known biomarkers of kidney function or injury ( e.g. , hepatitis A virus cellular receptor 1 [HAVCR1]/kidney injury molecule-1 [KIM-1], uromodulin [UMOD], ephrins), related to red cell physiology or hemolysis (erythropoietin [EPO], heme oxygenase 1 [HMOX1], and α -hemoglobin stabilizing protein) and/or inflammation (fractalkine, C-C motif chemokine ligand 2/monocyte chemoattractant protein-1 [MCP-1], and urokinase plasminogen activator surface receptor [PLAUR]). A protein risk score constructed from the top sickle cell trait-associated biomarkers was associated with incident kidney failure among those with sickle cell trait during Women's Health Initiative follow-up (odds ratio, 1.32; 95% confidence interval, 1.10 to 1.58).
We identified and replicated the association of sickle cell trait with a number of plasma proteins related to hemolysis, kidney injury, and inflammation. |
doi_str_mv | 10.2215/CJN.0000000000000257 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10637465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2845657733</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-a688c7f0923f87717249ad905bc1b5d2e7b47b4f73bd83df1f9817eb426706403</originalsourceid><addsrcrecordid>eNpdUdtKAzEQDaLYWv0DkX30ZWuum-2TSL1VigpW8EEI2WzSRre7NclW_HtTWos6DMzAnHNmhgPAMYJ9jBE7G97d9-HvwIzvgC5ijKUDyF52tz1FHXDg_RuElBLM9kGHcEYIorALXi-tMdrpWmmf2DoJM50MrVNtJYOtp8mja4Ju5no1G9WlXdqylZVPPm2YJUvtfLvumzYkT1a9V5GuqyqZOGnDIdgzEayPNrUHnq-vJsPbdPxwMxpejFNFMhJSmeW54gYOMDE554hjOpBl_KFQqGAl1rygMQ0nRZmT0iAzyBHXBcUZhxmFpAfO17qLtpjrUuk6OFmJhbNz6b5EI634O6ntTEybpUAwI5xmLCqcbhRc89FqH8TcehUfkbVuWi9wTlnGOCckQukaqlzjvdNmuwdBsXJGRGfEf2ci7eT3jVvSjxXkGw9SinA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2845657733</pqid></control><display><type>article</type><title>Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Cai, Yanwei ; Franceschini, Nora ; Surapaneni, Aditya ; Garrett, Melanie E ; Tahir, Usman A ; Hsu, Li ; Telen, Marilyn J ; Yu, Bing ; Tang, Hua ; Li, Yun ; Liu, Simin ; Gerszten, Robert E ; Coresh, Josef ; Manson, JoAnn E ; Wojcik, Genevieve L ; Kooperberg, Charles ; Auer, Paul L ; Foster, Matthew W ; Grams, Morgan E ; Ashley-Koch, Allison E ; Raffield, Laura M ; Reiner, Alex P</creator><creatorcontrib>Cai, Yanwei ; Franceschini, Nora ; Surapaneni, Aditya ; Garrett, Melanie E ; Tahir, Usman A ; Hsu, Li ; Telen, Marilyn J ; Yu, Bing ; Tang, Hua ; Li, Yun ; Liu, Simin ; Gerszten, Robert E ; Coresh, Josef ; Manson, JoAnn E ; Wojcik, Genevieve L ; Kooperberg, Charles ; Auer, Paul L ; Foster, Matthew W ; Grams, Morgan E ; Ashley-Koch, Allison E ; Raffield, Laura M ; Reiner, Alex P</creatorcontrib><description>Sickle cell trait affects approximately 8% of Black individuals in the United States, along with many other individuals with ancestry from malaria-endemic regions worldwide. While traditionally considered a benign condition, recent evidence suggests that sickle cell trait is associated with lower eGFR and higher risk of kidney diseases, including kidney failure. The mechanisms underlying these associations remain poorly understood. We used proteomic profiling to gain insight into the pathobiology of sickle cell trait.
We measured proteomics ( N =1285 proteins assayed by Olink Explore) using baseline plasma samples from 592 Black participants with sickle cell trait and 1:1 age-matched Black participants without sickle cell trait from the prospective Women's Health Initiative cohort. Age-adjusted linear regression was used to assess the association between protein levels and sickle cell trait.
In age-adjusted models, 35 proteins were significantly associated with sickle cell trait after correction for multiple testing. Several of the sickle cell trait-protein associations were replicated in Black participants from two independent cohorts (Atherosclerosis Risk in Communities study and Jackson Heart Study) assayed using an orthogonal aptamer-based proteomic platform (SomaScan). Many of the validated sickle cell trait-associated proteins are known biomarkers of kidney function or injury ( e.g. , hepatitis A virus cellular receptor 1 [HAVCR1]/kidney injury molecule-1 [KIM-1], uromodulin [UMOD], ephrins), related to red cell physiology or hemolysis (erythropoietin [EPO], heme oxygenase 1 [HMOX1], and α -hemoglobin stabilizing protein) and/or inflammation (fractalkine, C-C motif chemokine ligand 2/monocyte chemoattractant protein-1 [MCP-1], and urokinase plasminogen activator surface receptor [PLAUR]). A protein risk score constructed from the top sickle cell trait-associated biomarkers was associated with incident kidney failure among those with sickle cell trait during Women's Health Initiative follow-up (odds ratio, 1.32; 95% confidence interval, 1.10 to 1.58).
We identified and replicated the association of sickle cell trait with a number of plasma proteins related to hemolysis, kidney injury, and inflammation.</description><identifier>ISSN: 1555-9041</identifier><identifier>ISSN: 1555-905X</identifier><identifier>EISSN: 1555-905X</identifier><identifier>DOI: 10.2215/CJN.0000000000000257</identifier><identifier>PMID: 37533140</identifier><language>eng</language><publisher>United States: American Society of Nephrology</publisher><subject>Biomarkers ; Clinical Nephrology ; Female ; Hemolysis ; Humans ; Inflammation ; Original ; Prospective Studies ; Proteome ; Proteomics ; Renal Insufficiency ; Sickle Cell Trait ; United States</subject><ispartof>Clinical journal of the American Society of Nephrology, 2023-11, Vol.18 (11), p.1416-1425</ispartof><rights>Copyright © 2023 by the American Society of Nephrology.</rights><rights>Copyright © 2023 by the American Society of Nephrology 2023</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-a688c7f0923f87717249ad905bc1b5d2e7b47b4f73bd83df1f9817eb426706403</citedby><cites>FETCH-LOGICAL-c363t-a688c7f0923f87717249ad905bc1b5d2e7b47b4f73bd83df1f9817eb426706403</cites><orcidid>0000-0003-3809-1780 ; 0000-0001-7206-8088 ; 0000-0003-2302-6150 ; 0000-0003-4818-1077 ; 0000-0002-4598-0669 ; 0000-0002-6767-7687 ; 0000-0003-4978-5980 ; 0000-0001-8168-4712 ; 0000-0002-4430-6023 ; 0000-0002-7892-193 ; 0000-0002-9426-7595 ; 0000-0001-5409-9155 ; 0000-0002-3950-3794 ; 0000-0003-0212-2346 ; 0000-0003-1735-8044 ; 0000-0002-9275-4189 ; 0000-0003-2098-3844 ; 0000-0002-7892-193X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637465/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637465/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37533140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cai, Yanwei</creatorcontrib><creatorcontrib>Franceschini, Nora</creatorcontrib><creatorcontrib>Surapaneni, Aditya</creatorcontrib><creatorcontrib>Garrett, Melanie E</creatorcontrib><creatorcontrib>Tahir, Usman A</creatorcontrib><creatorcontrib>Hsu, Li</creatorcontrib><creatorcontrib>Telen, Marilyn J</creatorcontrib><creatorcontrib>Yu, Bing</creatorcontrib><creatorcontrib>Tang, Hua</creatorcontrib><creatorcontrib>Li, Yun</creatorcontrib><creatorcontrib>Liu, Simin</creatorcontrib><creatorcontrib>Gerszten, Robert E</creatorcontrib><creatorcontrib>Coresh, Josef</creatorcontrib><creatorcontrib>Manson, JoAnn E</creatorcontrib><creatorcontrib>Wojcik, Genevieve L</creatorcontrib><creatorcontrib>Kooperberg, Charles</creatorcontrib><creatorcontrib>Auer, Paul L</creatorcontrib><creatorcontrib>Foster, Matthew W</creatorcontrib><creatorcontrib>Grams, Morgan E</creatorcontrib><creatorcontrib>Ashley-Koch, Allison E</creatorcontrib><creatorcontrib>Raffield, Laura M</creatorcontrib><creatorcontrib>Reiner, Alex P</creatorcontrib><title>Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait</title><title>Clinical journal of the American Society of Nephrology</title><addtitle>Clin J Am Soc Nephrol</addtitle><description>Sickle cell trait affects approximately 8% of Black individuals in the United States, along with many other individuals with ancestry from malaria-endemic regions worldwide. While traditionally considered a benign condition, recent evidence suggests that sickle cell trait is associated with lower eGFR and higher risk of kidney diseases, including kidney failure. The mechanisms underlying these associations remain poorly understood. We used proteomic profiling to gain insight into the pathobiology of sickle cell trait.
We measured proteomics ( N =1285 proteins assayed by Olink Explore) using baseline plasma samples from 592 Black participants with sickle cell trait and 1:1 age-matched Black participants without sickle cell trait from the prospective Women's Health Initiative cohort. Age-adjusted linear regression was used to assess the association between protein levels and sickle cell trait.
In age-adjusted models, 35 proteins were significantly associated with sickle cell trait after correction for multiple testing. Several of the sickle cell trait-protein associations were replicated in Black participants from two independent cohorts (Atherosclerosis Risk in Communities study and Jackson Heart Study) assayed using an orthogonal aptamer-based proteomic platform (SomaScan). Many of the validated sickle cell trait-associated proteins are known biomarkers of kidney function or injury ( e.g. , hepatitis A virus cellular receptor 1 [HAVCR1]/kidney injury molecule-1 [KIM-1], uromodulin [UMOD], ephrins), related to red cell physiology or hemolysis (erythropoietin [EPO], heme oxygenase 1 [HMOX1], and α -hemoglobin stabilizing protein) and/or inflammation (fractalkine, C-C motif chemokine ligand 2/monocyte chemoattractant protein-1 [MCP-1], and urokinase plasminogen activator surface receptor [PLAUR]). A protein risk score constructed from the top sickle cell trait-associated biomarkers was associated with incident kidney failure among those with sickle cell trait during Women's Health Initiative follow-up (odds ratio, 1.32; 95% confidence interval, 1.10 to 1.58).
We identified and replicated the association of sickle cell trait with a number of plasma proteins related to hemolysis, kidney injury, and inflammation.</description><subject>Biomarkers</subject><subject>Clinical Nephrology</subject><subject>Female</subject><subject>Hemolysis</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Original</subject><subject>Prospective Studies</subject><subject>Proteome</subject><subject>Proteomics</subject><subject>Renal Insufficiency</subject><subject>Sickle Cell Trait</subject><subject>United States</subject><issn>1555-9041</issn><issn>1555-905X</issn><issn>1555-905X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUdtKAzEQDaLYWv0DkX30ZWuum-2TSL1VigpW8EEI2WzSRre7NclW_HtTWos6DMzAnHNmhgPAMYJ9jBE7G97d9-HvwIzvgC5ijKUDyF52tz1FHXDg_RuElBLM9kGHcEYIorALXi-tMdrpWmmf2DoJM50MrVNtJYOtp8mja4Ju5no1G9WlXdqylZVPPm2YJUvtfLvumzYkT1a9V5GuqyqZOGnDIdgzEayPNrUHnq-vJsPbdPxwMxpejFNFMhJSmeW54gYOMDE554hjOpBl_KFQqGAl1rygMQ0nRZmT0iAzyBHXBcUZhxmFpAfO17qLtpjrUuk6OFmJhbNz6b5EI634O6ntTEybpUAwI5xmLCqcbhRc89FqH8TcehUfkbVuWi9wTlnGOCckQukaqlzjvdNmuwdBsXJGRGfEf2ci7eT3jVvSjxXkGw9SinA</recordid><startdate>20231101</startdate><enddate>20231101</enddate><creator>Cai, Yanwei</creator><creator>Franceschini, Nora</creator><creator>Surapaneni, Aditya</creator><creator>Garrett, Melanie E</creator><creator>Tahir, Usman A</creator><creator>Hsu, Li</creator><creator>Telen, Marilyn J</creator><creator>Yu, Bing</creator><creator>Tang, Hua</creator><creator>Li, Yun</creator><creator>Liu, Simin</creator><creator>Gerszten, Robert E</creator><creator>Coresh, Josef</creator><creator>Manson, JoAnn E</creator><creator>Wojcik, Genevieve L</creator><creator>Kooperberg, Charles</creator><creator>Auer, Paul L</creator><creator>Foster, Matthew W</creator><creator>Grams, Morgan E</creator><creator>Ashley-Koch, Allison E</creator><creator>Raffield, Laura M</creator><creator>Reiner, Alex P</creator><general>American Society of Nephrology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3809-1780</orcidid><orcidid>https://orcid.org/0000-0001-7206-8088</orcidid><orcidid>https://orcid.org/0000-0003-2302-6150</orcidid><orcidid>https://orcid.org/0000-0003-4818-1077</orcidid><orcidid>https://orcid.org/0000-0002-4598-0669</orcidid><orcidid>https://orcid.org/0000-0002-6767-7687</orcidid><orcidid>https://orcid.org/0000-0003-4978-5980</orcidid><orcidid>https://orcid.org/0000-0001-8168-4712</orcidid><orcidid>https://orcid.org/0000-0002-4430-6023</orcidid><orcidid>https://orcid.org/0000-0002-7892-193</orcidid><orcidid>https://orcid.org/0000-0002-9426-7595</orcidid><orcidid>https://orcid.org/0000-0001-5409-9155</orcidid><orcidid>https://orcid.org/0000-0002-3950-3794</orcidid><orcidid>https://orcid.org/0000-0003-0212-2346</orcidid><orcidid>https://orcid.org/0000-0003-1735-8044</orcidid><orcidid>https://orcid.org/0000-0002-9275-4189</orcidid><orcidid>https://orcid.org/0000-0003-2098-3844</orcidid><orcidid>https://orcid.org/0000-0002-7892-193X</orcidid></search><sort><creationdate>20231101</creationdate><title>Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait</title><author>Cai, Yanwei ; Franceschini, Nora ; Surapaneni, Aditya ; Garrett, Melanie E ; Tahir, Usman A ; Hsu, Li ; Telen, Marilyn J ; Yu, Bing ; Tang, Hua ; Li, Yun ; Liu, Simin ; Gerszten, Robert E ; Coresh, Josef ; Manson, JoAnn E ; Wojcik, Genevieve L ; Kooperberg, Charles ; Auer, Paul L ; Foster, Matthew W ; Grams, Morgan E ; Ashley-Koch, Allison E ; Raffield, Laura M ; Reiner, Alex P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-a688c7f0923f87717249ad905bc1b5d2e7b47b4f73bd83df1f9817eb426706403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Biomarkers</topic><topic>Clinical Nephrology</topic><topic>Female</topic><topic>Hemolysis</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Original</topic><topic>Prospective Studies</topic><topic>Proteome</topic><topic>Proteomics</topic><topic>Renal Insufficiency</topic><topic>Sickle Cell Trait</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cai, Yanwei</creatorcontrib><creatorcontrib>Franceschini, Nora</creatorcontrib><creatorcontrib>Surapaneni, Aditya</creatorcontrib><creatorcontrib>Garrett, Melanie E</creatorcontrib><creatorcontrib>Tahir, Usman A</creatorcontrib><creatorcontrib>Hsu, Li</creatorcontrib><creatorcontrib>Telen, Marilyn J</creatorcontrib><creatorcontrib>Yu, Bing</creatorcontrib><creatorcontrib>Tang, Hua</creatorcontrib><creatorcontrib>Li, Yun</creatorcontrib><creatorcontrib>Liu, Simin</creatorcontrib><creatorcontrib>Gerszten, Robert E</creatorcontrib><creatorcontrib>Coresh, Josef</creatorcontrib><creatorcontrib>Manson, JoAnn E</creatorcontrib><creatorcontrib>Wojcik, Genevieve L</creatorcontrib><creatorcontrib>Kooperberg, Charles</creatorcontrib><creatorcontrib>Auer, Paul L</creatorcontrib><creatorcontrib>Foster, Matthew W</creatorcontrib><creatorcontrib>Grams, Morgan E</creatorcontrib><creatorcontrib>Ashley-Koch, Allison E</creatorcontrib><creatorcontrib>Raffield, Laura M</creatorcontrib><creatorcontrib>Reiner, Alex P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cai, Yanwei</au><au>Franceschini, Nora</au><au>Surapaneni, Aditya</au><au>Garrett, Melanie E</au><au>Tahir, Usman A</au><au>Hsu, Li</au><au>Telen, Marilyn J</au><au>Yu, Bing</au><au>Tang, Hua</au><au>Li, Yun</au><au>Liu, Simin</au><au>Gerszten, Robert E</au><au>Coresh, Josef</au><au>Manson, JoAnn E</au><au>Wojcik, Genevieve L</au><au>Kooperberg, Charles</au><au>Auer, Paul L</au><au>Foster, Matthew W</au><au>Grams, Morgan E</au><au>Ashley-Koch, Allison E</au><au>Raffield, Laura M</au><au>Reiner, Alex P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait</atitle><jtitle>Clinical journal of the American Society of Nephrology</jtitle><addtitle>Clin J Am Soc Nephrol</addtitle><date>2023-11-01</date><risdate>2023</risdate><volume>18</volume><issue>11</issue><spage>1416</spage><epage>1425</epage><pages>1416-1425</pages><issn>1555-9041</issn><issn>1555-905X</issn><eissn>1555-905X</eissn><abstract>Sickle cell trait affects approximately 8% of Black individuals in the United States, along with many other individuals with ancestry from malaria-endemic regions worldwide. While traditionally considered a benign condition, recent evidence suggests that sickle cell trait is associated with lower eGFR and higher risk of kidney diseases, including kidney failure. The mechanisms underlying these associations remain poorly understood. We used proteomic profiling to gain insight into the pathobiology of sickle cell trait.
We measured proteomics ( N =1285 proteins assayed by Olink Explore) using baseline plasma samples from 592 Black participants with sickle cell trait and 1:1 age-matched Black participants without sickle cell trait from the prospective Women's Health Initiative cohort. Age-adjusted linear regression was used to assess the association between protein levels and sickle cell trait.
In age-adjusted models, 35 proteins were significantly associated with sickle cell trait after correction for multiple testing. Several of the sickle cell trait-protein associations were replicated in Black participants from two independent cohorts (Atherosclerosis Risk in Communities study and Jackson Heart Study) assayed using an orthogonal aptamer-based proteomic platform (SomaScan). Many of the validated sickle cell trait-associated proteins are known biomarkers of kidney function or injury ( e.g. , hepatitis A virus cellular receptor 1 [HAVCR1]/kidney injury molecule-1 [KIM-1], uromodulin [UMOD], ephrins), related to red cell physiology or hemolysis (erythropoietin [EPO], heme oxygenase 1 [HMOX1], and α -hemoglobin stabilizing protein) and/or inflammation (fractalkine, C-C motif chemokine ligand 2/monocyte chemoattractant protein-1 [MCP-1], and urokinase plasminogen activator surface receptor [PLAUR]). A protein risk score constructed from the top sickle cell trait-associated biomarkers was associated with incident kidney failure among those with sickle cell trait during Women's Health Initiative follow-up (odds ratio, 1.32; 95% confidence interval, 1.10 to 1.58).
We identified and replicated the association of sickle cell trait with a number of plasma proteins related to hemolysis, kidney injury, and inflammation.</abstract><cop>United States</cop><pub>American Society of Nephrology</pub><pmid>37533140</pmid><doi>10.2215/CJN.0000000000000257</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-3809-1780</orcidid><orcidid>https://orcid.org/0000-0001-7206-8088</orcidid><orcidid>https://orcid.org/0000-0003-2302-6150</orcidid><orcidid>https://orcid.org/0000-0003-4818-1077</orcidid><orcidid>https://orcid.org/0000-0002-4598-0669</orcidid><orcidid>https://orcid.org/0000-0002-6767-7687</orcidid><orcidid>https://orcid.org/0000-0003-4978-5980</orcidid><orcidid>https://orcid.org/0000-0001-8168-4712</orcidid><orcidid>https://orcid.org/0000-0002-4430-6023</orcidid><orcidid>https://orcid.org/0000-0002-7892-193</orcidid><orcidid>https://orcid.org/0000-0002-9426-7595</orcidid><orcidid>https://orcid.org/0000-0001-5409-9155</orcidid><orcidid>https://orcid.org/0000-0002-3950-3794</orcidid><orcidid>https://orcid.org/0000-0003-0212-2346</orcidid><orcidid>https://orcid.org/0000-0003-1735-8044</orcidid><orcidid>https://orcid.org/0000-0002-9275-4189</orcidid><orcidid>https://orcid.org/0000-0003-2098-3844</orcidid><orcidid>https://orcid.org/0000-0002-7892-193X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1555-9041 |
ispartof | Clinical journal of the American Society of Nephrology, 2023-11, Vol.18 (11), p.1416-1425 |
issn | 1555-9041 1555-905X 1555-905X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10637465 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Biomarkers Clinical Nephrology Female Hemolysis Humans Inflammation Original Prospective Studies Proteome Proteomics Renal Insufficiency Sickle Cell Trait United States |
title | Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T12%3A32%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differences%20in%20the%20Circulating%20Proteome%20in%20Individuals%20with%20versus%20without%20Sickle%20Cell%20Trait&rft.jtitle=Clinical%20journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Cai,%20Yanwei&rft.date=2023-11-01&rft.volume=18&rft.issue=11&rft.spage=1416&rft.epage=1425&rft.pages=1416-1425&rft.issn=1555-9041&rft.eissn=1555-905X&rft_id=info:doi/10.2215/CJN.0000000000000257&rft_dat=%3Cproquest_pubme%3E2845657733%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2845657733&rft_id=info:pmid/37533140&rfr_iscdi=true |